Meadow Creek Investment Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $453K | Buy |
15,810
+850
| +6% | +$24.4K | 0.01% | 751 |
|
|
2019
Q2 | $416K | Buy |
14,960
+646
| +5% | +$18K | 0.01% | 783 |
|
|
2019
Q1 | $475K | Hold |
14,314
| – | – | 0.01% | 704 |
|
|
2018
Q4 | $416K | Hold |
14,314
| – | – | 0.01% | 702 |
|
|
2018
Q3 | $659K | Buy |
14,314
+918
| +7% | +$42.3K | 0.01% | 613 |
|
|
2018
Q2 | $501K | Hold |
13,396
| – | – | 0.01% | 652 |
|
|
2018
Q1 | $396K | Buy |
13,396
+2,074
| +18% | +$61.3K | 0.01% | 741 |
|
|
2017
Q4 | $389K | Buy |
11,322
+1,836
| +19% | +$63.1K | 0.01% | 750 |
|
|
2017
Q3 | $343K | Buy |
9,486
+1,530
| +19% | +$55.3K | 0.01% | 726 |
|
|
2017
Q2 | $206K | Buy |
7,956
+3,604
| +83% | +$93.3K | ﹤0.01% | 866 |
|
|
2017
Q1 | $84K | Buy |
+4,352
| New | +$84K | ﹤0.01% | 996 |
|